Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Neural mechanisms of awareness of action.

PNAS nexus·2026
Same author

IGFBP5 suppresses colorectal cancer stemness and carcinogenesis via binding to GPR182 and inhibiting PKCα/AKT/P70S6K axis.

Biochemical pharmacology·2026
Same author

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Gut·2026
Same author

Antagonistic Regulation of the Conifer Age Marker DAL1 by GA and JA Via a TIFY25-DPL1 Module.

Plant, cell & environment·2026
Same author

lncRNA-EBLN3P promotes triple-negative breast cancer metastasis via activating Wnt/β-catenin signaling pathway.

Discover oncology·2026
Same author

Paternal fenvalerate exposure causes autism-like behavior partly by altering epigenetic reprogramming of the imprinted gene IGF2 in fetal brain and paternal sperm.

Ecotoxicology and environmental safety·2026

相关实验视频

Updated: Jan 15, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

对于直肠癌的横向淋巴结解剖的研究进展.

Miao-Miao Dong1, Zheng-Peng Qian2, Ji-Yong Lu3

  • 1Gansu Province Hospital Rehabilitation Center, Lanzhou, Gansu, China.

Frontiers in oncology
|October 16, 2025
PubMed
概括

侧侧淋巴结解剖 (LLND) 是低直肠癌的关键手术,旨在去除淋巴结并防止复发. 这篇评论分析了LLND和LLND.

关键词:
侧侧淋巴结解剖 (LLND) 是一种方法.低直肠癌是直肠癌的一种.新辅助性化疗或放射治疗 (NCRT)机器人辅助手术是一种机器人辅助的手术.整体腹腔切除术 (TME) 是一种全腹腔切除术.

更多相关视频

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

1.4K
The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery
05:43

The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery

Published on: August 1, 2025

614

相关实验视频

Last Updated: Jan 15, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

1.4K
The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery
05:43

The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery

Published on: August 1, 2025

614

科学领域:

  • 在瘤学瘤学.
  • 手术瘤学手术瘤学
  • 胃肠病学 胃肠病学

背景情况:

  • 侧侧淋巴结解剖 (LLND) 对于低直肠癌治疗至关重要.
  • 它的目标是切除侧侧的盆腔淋巴结,防止转移和复发.
  • 在日本,LLND是标准的,但在欧洲和北美有争议,新辅助化学辐射疗法 (nCRT) 主导.

研究的目的:

  • 提供LLND对低直肠癌的综合分析.
  • 审查技术发展,临床疗效,以及围绕LLND.的争议.
  • 在临床实践中指导LLND的合理应用和优化.

主要方法:

  • 整合最新的临床研究成果LLND.
  • 对LLND技术发展和临床疗效的分析.
  • 客观地呈现学术争议和未来发展.

主要成果:

  • LLND旨在通过治疗侧侧盆腔淋巴结来改善低直肠癌的结果.
  • 对LLND的有效性和应用进行了辩论,日本与欧洲/北美标准不同.
  • 持续的研究和技术进步正在塑造LLND的未来.

结论:

  • 尽管正在进行辩论,LLND仍然是低直肠癌的重要干预措施.
  • 对其有效性,争议和技术方面的全面了解对于最佳的患者护理至关重要.
  • 未来的发展可能会进一步完善LLND在直肠癌治疗中的作用.